Home › Meningioma › Indiana
Meningioma clinical trials in Indiana
3 studies for Meningioma are looking for participants at sites in Indiana.
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Indiana University, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06955169Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- Indiana University School of Medicine, Indianopolis
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 2, 2026 · NCT04374305Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Goodman Campbell Brain and Spine, Carmel
- Indiana University, IU Health Methodist Hospital, Indianapolis
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.